SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-032627
Filing Date
2022-11-16
Accepted
2022-11-16 16:15:20
Documents
2
Period of Report
2022-11-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1630
2 ex24-1.htm EX-24.1 16965
  Complete submission text file 0001493152-22-032627.txt   20074
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DTX PHARMA, INC. 10655 SORRENTO VALLEY ROAD, SUITE 100 SAN DIEGO CA 92121
Business Address
Howe Jill Ann (Reporting) CIK: 0001892397 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12830 | Film No.: 221395332